Your session is about to expire
← Back to Search
Inhaled Steroids for Spinal Cord Injury
Study Summary
This trial will test the effects of pharmacological intervention on individuals with chronic cervical SCI who share many aspects of obstructive airway physiology commonly associated with asthma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2010 Phase 3 trial • 333 Patients • NCT01135134Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My medical records show I have adrenal insufficiency.I have a history of glaucoma.I have a pressure ulcer or a wound that healed within the last 3 months.You have had an allergy to milk protein in the past.I have an active lung condition like COPD or asthma.I am not taking medications that affect my breathing or interact with mometasone.I have never had asthma and no recent respiratory infections.I have a history of cataracts.I am between 18 and 65 years old.I have had stable paralysis in my limbs due to a neck injury for over a year.You have smoked or been around smoke in the past six months.I am able to understand and make decisions about my health care.My medical records show I have heart or artery disease.You rely on a ventilator for breathing.You have high blood pressure with a starting blood pressure of 140/90 mmHg or higher.
- Group 1: Asmanex
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What indications is Mometasone furoate typically prescribed for?
"Mometasone furoate is frequently used for the treatment of dermatitis, eczematous caused by superficial fungal skin infections. This medication can additionally be prescribed to manage conditions like psoriasis, seasonal allergic rhinitis, and cutaneous bacterial illnesses."
Is this investigation actively recruiting individuals aged sixty and older?
"The requirements for entry into this trial stipulate that participants must be between 18 to 65 years old. Moreover, there are 140 studies open to minors and 737 trials available for seniors."
Am I eligible to participate in this experiment?
"This research project is in search of 50 individuals aged 18-65 who have sustained a spinal cord injury. To be included, participants must satisfy the following criteria: mature enough to grant consent and not exceeding 65 years old."
Are there currently any opportunities for patients to participate in this experiment?
"This scientific investigation is not currently accepting candidates, having been initially advertised on August 1st 2011 and last updated October 22nd 2015. Alternately, there are 902 active trials for spinal cord injuries as well as 6 recruiting studies related to Mometasone furoate that participants can explore."
Is Mometasone furoate generally safe for human consumption?
"As we are in the early stages of testing for Mometasone Furoate, our team at Power has deemed it a 1 on a scale from 1 to 3 due to limited data regarding its safety and efficacy."
What is the aggregate tally of participants in this research project?
"This medical trial is not available for participation at this time. It was first posted on August 1st 2011, with the most recent update occurring in October of 2015. Currently, there are 902 clinical trials seeking participants with spinal cord injuries and 6 studies recruiting patients to test Mometasone furoate."
What prior investigations have been conducted into the efficacy of Mometasone furoate?
"Mometasone furoate was first examined in 2006 at Oulu University Hospital's Department of Children and Adolescents. There are presently 119 completed studies, with 6 ongoing trials primarily based in the Bronx, New york City."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger